Kriya Therapeutics, Inc.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING6
READOUTS ≤12 MONTHS0
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| VISION NCT06765980 |
P1/2 | Recruiting | Geographic Atrophy Secondary to Age-related Macular Degeneration | 62 | 2027-12-15 |
| RESTORE NCT07732400 |
P1/2 | Recruiting | Metabolic Dysfunction-associated Steatohepatitis (MASH) | 56 | 2028-07 |
| RECLAIM NCT07404111 |
P1/2 | Recruiting | Thyroid Eye Disease (TED) | 135 | 2028-08 |
| RELIEVE NCT07831798 |
P1/2 | Recruiting | Type 1 Diabetes Mellitus | 29 | 2028-11 |
| RELIEF NCT07596485 |
P1/2 | Recruiting | Trigeminal Neuralgia | 24 | 2029-02 |
| PROGRESS NCT07829302 |
P1/2 | Recruiting | Type 1 Diabetes Mellitus | 29 | 2029-07 |